Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
| 21.5 | |
| 21.5 | |
| - | |
| 21.6 | |
| 21 | |
| 19.325-45 | |
| 95 914 K | |
| 3.0714 | |
| 446 M | |
| 43 085 M | |
| 2.1983 | |
| 0.117 | |
| 0.636 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
(Recasts, adds background on rival pill, quote, updates share price) By Sachin Ravikumar Nov 9 (Reuters) - A Bangladeshi drugmaker will soon begin selling the world's first generic version of Merck'...
By Sachin Ravikumar (Reuters) -A Bangladeshi drugmaker will soon begin selling the world's first generic version of Merck's COVID-19 pill, molnupiravir, which has been touted as a potential game-chan...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
